P099 Effect of a mucolytic agent delivered through sinus pulsating aerosol system (SPAS) device on sinonasal symptoms and patient report outcomes in people with cystic fibrosis (PwCF)

Autor: Cartagena, M.N. Balaguer, Acosta, R. Mellidez, Piñero, A. Garcia, Ferrer, M.J. Selma, Díaz, P. García, Mezquida, J.P. Reig, Muñoz, I. Pérez, Jover, A. Solé
Zdroj: In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S94-S94
Databáze: ScienceDirect